Full trial results of EASE-SBS 1 expected in the third quarter of 2022 Pending positive pivotal data, Zealand intends to file for marketing approval with the U.S. Food and Drug Administration The ...
Denmark-based Zealand Pharma A/S ZEAL announced that it has completed enrollment of patients in the pivotal phase III EASE-SBS 1 study that is evaluating its long-acting GLP-2 analog, glepaglutide, ...
The bq34z653 SBS-compliant gas gauge and protection IC, incorporating patented Impedance Track™ technology, is a single IC solution designed for battery-pack or in-system installation. The bq34z653 ...
Welcome to SBS News in Easy English, I'm Camille Bianchi. Australia will spend 48 million dollars to help countries in the Pacific prevent and treat HIV infections. Dash Heath-Paynter, is CEO of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results